Estimated reading time: 5 minutes
Table of contents
Introduction
North Carolina remains one of the few states without a medical cannabis program, despite strong support among voters. In recent years, the North Carolina Senate has passed medical cannabis legalization bills in both 2022 and 2023—most notably, a 36-10 supermajority in support of allowing qualified patients access to cannabis. However, these efforts have stalled in the House, leaving the state’s medical cannabis future uncertain as we look toward 2025.
Legislative Setbacks in the House
Both Senate bills failed to advance in the lower chamber. Former House Speaker Tim Moore explained that under his leadership, a bill could not proceed unless it had sufficient backing from his caucus. Even proposals with 100% Democratic support, but only 49% Republican backing, did not meet the threshold. Although the House recently elected a new speaker for the first time in 10 years, early signals are not optimistic for reform. Rep. Destin Hall, R-Caldwell—who has long opposed medical cannabis legalization—now holds the keys to the floor, potentially stalling future efforts.
Senate Support and Public Opinion
In contrast to the House, the upper chamber remains more receptive to reform. Senate President Pro Tempore Phil Berger, R-Guilford, has indicated openness to legalization—as long as any legislation addresses concerns regarding unregulated THC products derived from hemp. “It seems to me that there’s an opportunity there to address the medical marijuana issue at some point during the session,” Berger told Queen City News on January 29.
Senate Minority Leader Sydney Batch, D-Wake, has highlighted that medical cannabis, along with casinos, are nonpartisan issues the General Assembly could tackle. This sentiment is echoed by North Carolina voters: a September 2024 WRAL News poll found that 70% support medical cannabis legalization, and a February 2024 Meredith College survey reported 71% support.
Conclusion
With no cannabis legalization reform bills filed as of mid-February and the legislative session set to run through July 31, North Carolina remains one of eight states without a medical cannabis program—even when compared to states with very restrictive models like Texas. Meanwhile, the state’s 21-and-older population already has limited access to adult-use cannabis on the Eastern Band of Cherokee Indians’ reservation in the Qualla Boundary. As North Carolina heads into 2025, the future of Cannabis Legalization North Carolina hangs in the balance, with a divided House posing a significant obstacle despite robust Senate backing and widespread public support.
Cannabis Legalization North Carolina 2025 FAQs
No, recreational marijuana is not legal in North Carolina. It is only legal for limited medical use.
In the state of North Carolina, you cannot purchase cannabis from dispensaries without a medical card. The state’s medical cannabis program requires individuals to have a qualifying condition and possess a medical cannabis card to buy cannabis products legally.
Anyone over 21 with a valid ID can purchase THC products in Western North Carolina. Sales began Sept. 7, 2024 at 10 a.m. at the old bingo hall on the western end of the Qualla Boundary.
While North Carolina has yet to legalize recreational marijuana, there are strict prohibitions in place against the sale and distribution of cannabis, including the following: Sale 10 pounds or less: A Class I felony punishable by three to eight months imprisonment and a discretionary fine for a first offense.
No, you cannot buy marijuana in North Carolina for recreational use, except for limited medical use. Possession of 0.5 ounces or less is decriminalized for people with three or fewer misdemeanor convictions.
In the state of North Carolina the following medical conditions can qualify patients for a medical marijuana card are the following, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), cancer, epilepsy, amyotrophic lateral sclerosis (ALS), Crohn’s disease, and more.
Additional Resources
Free eBooks For Cannabis Business Success
Latest Articles
- The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase. - Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City. - New York Cannabis Lounge License: Expert Guide to Compliance and Success
The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation. - The 2026 New York Execution Gap: Scaling Your Cannabis Business
The trajectory of the New York cannabis industry has transitioned from a period of experimental regulation to one of massive commercial consolidation and operational intensity. As of April 15, 2026, the state has officially matured into its role as the second-largest cannabis market in the United States, trailing only California in total economic activity and consumer demand. The primary indicator of this success is the milestone reached in early 2026, where total reported retail sales since the inception of the legal program surpassed $2.97 billion. - Regulatory Maturity and Market Dynamics: A Comprehensive Analysis of the New Jersey Cannabis Industry
The legal landscape of cannabis in New Jersey has transitioned from a period of rapid legislative enactment into an era of complex regulatory maturity and secondary market correction. Since the foundational passage of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) in early 2021, the state has systematically dismantled the architecture of prohibition while constructing a highly regulated, billion-dollar industry. - Nebraska Medical Cannabis Market Strategic Report: Navigating the Regulatory Landscape and Licensing Framework 2026
The Nebraska medical cannabis industry has undergone a radical transformation from its nascent beginnings in the 2024 general election to the highly structured, albeit restrictive, regulatory environment of April 2026. This period has been characterized by intense legislative maneuvering, high-stakes licensing competitions, and a fundamental shift in the state’s administrative approach to controlled substances.